Pharmaceutical giant AstraZeneca is to manufacture and distribute a coronavirus vaccine that is being developed by the University of Oxford, if the treatment proves effective.

AstraZeneca's chief executive Pascal Soriot tells the BBC why his firm has chosen to back Oxford in developing a vaccine.